| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | FG|Fibrinogen |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target |
Background
human FG (Fibrinogen) is a molecular target commonly studied in biomedical research. Circulating plasma proteins support transport, buffering, and homeostatic processes in blood and extracellular fluids.
Biological role and mechanism
The biological role of FG is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of FG can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
FG (Fibrinogen) may also be referenced as FG and Fibrinogen in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how FG relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.
- Interpreting shifts in FG levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
FG has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
A single nuclear transcriptomic characterisation of mechanisms responsible for impaired angiogenesis and blood-brain barrier function in Alzheimer's disease
IF: 16.6 Journal: Nature Communications Author: Department of Brain Sciences, Imperial College London, London, UK. Cited Date: 2024-05-06
Post-mortem evidence of pathogenic angiogenesis and abnormal vascular function in early Alzheimer's disease
IF: 11.7 Journal: Brain Author: Cerebrovascular & Dementia Research Group, Bristol Medical School, University of Bristol, Learning and Research Building, Bristol, BS10 5NB, UK. Cited Date: 2025-10-31
Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease
IF: 11.337 Journal: Brain Cited Date: 2021-04-02
Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease
IF: 6.8 Journal: Translational Psychiatry Author: Wisconsin Alzheimer’s Disease Research Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA Cited Date: 2024-01-12
Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia
IF: 5.568 Journal: Brain Pathology Cited Date: 2021-01-26
Differing associations between Ab accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer’s disease
IF: 4.929 Journal: Cerebral Blood Flow & Metabolism Cited Date: 2017-01-01
Patho- physiological role of BDNF in fibrin clotting
IF: 4.847 Journal: Scientific Reports Cited Date: 2019-01-23
Expression of Hemoglobin and Fibrinogen is Correlated with the Attack of Acute Arterial Embolism of the Lower Extremity
IF: 0.687 Journal: Pakistan Journal of Zoology Author: Department of Interventional Radiology, Qinghai Provincial People’s Hospital, No. 2 Gonghe Road, Xining, Qinghai 810007, China Cited Date: 2023-06-16
Markers of Systemic Inflammation in Smoker and Non-Smoker Chronic Obstructive Pulmonary Diseases
IF: Journal: Pakistan Journal of Health Sciences (Lahore) Author: Department of Medicine, University College of Medical Sciences and Guru Teg Bahadur Hospital, Delhi, India Cited Date: 2024-12-13
Elevated late-life blood pressure may maintain brain oxygenation and slow amyloid-β accumulation, at the expense of cerebral vascular damage
IF: Journal: Brain Communications Cited Date: 2023-04-14